Brugada syndrome in children: Don't ask, don't tell?

Circulation

Volumn 115, Issue 15, 2007, Pages 1970-1972

  Viskin, Sami ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Antiarrhythmia agents; Brugada syndrome; Death, sudden; Editorials; Electrical stimulation; Genetics; Tachyarrhythmias

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ESTROGEN; QUINIDINE; SODIUM CHANNEL BLOCKING AGENT; TESTOSTERONE;

ACTION POTENTIAL; BRUGADA SYNDROME; CELL DEGENERATION; CONVULSIVE THERAPY; DEFIBRILLATOR; EDITORIAL; ELECTROCARDIOGRAM; GENE MUTATION; GENETIC DISORDER; HEART ARREST; HEART ARRHYTHMIA; HEART FUNCTION TEST; HEART MUSCLE CELL; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; NONHUMAN; PRIORITY JOURNAL; RESUSCITATION; SYNCOPE; TRICUSPID VALVE REGURGITATION; VEIN OCCLUSION;

ADOLESCENT; ADULT; AGE FACTORS; ANTI-ARRHYTHMIA AGENTS; BRUGADA SYNDROME; CHILD; DEFIBRILLATORS, IMPLANTABLE; DIRECTIVE COUNSELING; ELECTROCARDIOGRAPHY; FEMALE; GENES, DOMINANT; HUMANS; MALE; MIDDLE AGED; QUINIDINE; SEX FACTORS; VENTRICULAR FIBRILLATION;

EID: 34247188185     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.106.686758     Document Type: Editorial

References (23)

1. Viskin S. Inducible ventricular fibrillation in the Brugada syndrome: diagnostic and prognostic implications. J Cardiovasc Electrophysiol. 2003;14:458-460.
2. Paul M, Schulze-Bahr E, Vahlhaus C, Gerss V, Breithardt G, Wichter T, Eckardt L. Impact of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Heart Rhythm. 2006;3:S79. Abstract.
3. Brugada P, Geelen P, Brugada R, Mont L, Brugada J. Prognostic value of electrophysiologic investigations in Brugada syndrome. J Cardiovasc Electrophysiol. 2001;12:1004-1007.
4. Gehi AK, Duong TD, Metz LD, Gomes JA, Mehta D. Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis. J Cardiovasc Electrophysiol. 2006;17:577-583.
5. Eckardt L, Probst V, Smits JP, Bahr ES, Wolpert C, Schimpf R, Wichter T, Boisseau P, Heinecke A, Breithardt G, Borggrefe M, LeMarec H, Bocker D, Wilde AA. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation. 2005;111:257-263.
6. Sacher F, Probst V, Iesaka Y, Jacon P, Laborderie J, Mizon-Gerard F, Mabo P, Reuter S, Lamaison D, Takahashi Y, O'Neill MD, Garrigue S, Pierre B, Jais P, Pasquie JL, Hocini M, Salvador-Mazenq M, Nogami A, Amiel A, Defaye P, Bordachar P, Boveda S, Maury P, Klug D, Babuty D, Haissaguerre M, Mansourati J, Clementy J, Le Marec H. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study. Circulation. 2006;114:2317-2324.
7. Brugada P, Brugada R, Brugada J. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Patients with an asymptomatic Brugada electrocardiogram should undergo pharmacological and electrophysiological testing. Circulation. 2005;112:279-285.
8. Priori SG, Napolitano C. Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing? Management of patients with Brugada should not be based on programmed electrical stimulation. Circulation. 2005;112:285-292.
9. Probst V, Denjoy I, Meregalli PG, Amirault JC, Sacher F, Mansourati J, Babuty D, Villain E, Victor J, Schott J-J, Lupoglazoff JM, Mabo P, Veltmann C, Jesel L, Chevalier P, Clur S-AB, Haissaguerre M, Wolpert C, Le Marec H, Wilde AAM. Clinical aspects and prognosis of Brugada syndrome in children. Circulation. 2007;115:2042-2048.
10. Di Diego JM, Cordeiro JM, Goodrow RJ, Fish JM, Zygmunt AC, Perez GJ, Scornik FS, Antzelevitch C. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation. 2002;106:2004-2011.
11. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation. 1999;100:1660-1666.
12. Liu XK, Katchman A, Whitfield BH, Wan G, Janowski EM, Woosley RL, Ebert SN. In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc Res. 2003;57:28-36.
13. Bai CX, Kurokawa J, Tamagawa M, Nakaya H, Furukawa T. Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation. 2005;112:1701-1710.
14. Pham TV, Robinson RB, Danilo P Jr, Rosen MR. Effects of gonadal steroids on gender-related differences in transmural dispersion of L-type calcium current. Cardiovasc Res. 2002;53:752-762.
15. Frustaci A, Priori SG, Pieroni M, Chimenti C, Napolitano C, Rivolta I, Sanna T, Bellocci F, Russo MA. Cardiac histological substrate in patients with clinical phenotype of Brugada syndrome. Circulation. 2005;112:3680-3687.
16. Aiba T, Shimizu W, Hidaka I, Uemura K, Noda T, Zheng C, Kamiya A, Inagaki M, Sugimachi M, Sunagawa K. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model: high-resolution optical mapping study. J Am Coll Cardiol. 2006;47:2074-2085.
17. Shimizu W, Matsuo K, Kokubo Y, Satomi K, Kurita T, Noda T, Nagaya N, Suyama K, Aihara N, Kamakura S, Inamoto N, Akahoshi M, Tomoike H. Sex hormone and gender difference: role of testosterone on male predominance in Brugada syndrome. J Cardiovasc Electrophysiol. 2007;18:415-421.
18. Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation. 2004;110:1731-1737.
19. Hermida JS, Denjoy I, Clerc J, Extramiana F, Jarry G, Milliez P, Guicheney P, Di Fusco S, Rey JL, Cauchemez B, Leenhardt A. Hydroquinidine therapy in Brugada syndrome. J Am Coll Cardiol. 2004;43:1853-1860.
20. Silka MJ, Bar-Cohen Y. Pacemakers and implantable cardioverter- defibrillators in pediatric patients. Heart Rhythm. 2006;3:1360-1366.
21. Stephenson EA, Batra AS, Knilans TK, Gow RM, Gradaus R, Balaji S, Dubin AM, Rhee EK, Ro PS, Thogersen AM, Cecchin F, Triedman JK, Walsh EP, Berul CI. A multicenter experience with novel implantable cardioverter defibrillator configurations in the pediatric and congenital heart disease population. J Cardiovasc Electrophysiol. 2006;17:41-46.
22. Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol. 2001;12:268-272.
23. Belhassen B, Viskin S, Antzelevitch C. The Brugada syndrome: is an implantable cardioverter defibrillator the only therapeutic option? Pacing Clin Electrophysiol. 2002;25:1634-1640.